99873-50-4

Basic information

• Product Name: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate
• Synonyms: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate
• CAS NO: 99873-50-4
• Molecular Weight: 396.076
• Mol File: 99873-50-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate(99873-50-4)
• EPA Substance Registry System: 2,3-dibromo-3-(3',4'-dimethoxy)-phenyl ethyl propanoate(99873-50-4)

Safety Data

• Hazardous Substances Data: 99873-50-4(Hazardous Substances Data)

Upstream product

• 2316-26-9 3,4-dimethoxycinnamic acid 
• 14737-89-4 3,4-dimethoxy-trans-cinnamic acid 
• 20583-78-2 ethyl (E)-3,4-dimethoxycinnamate 
• 20583-78-2 3,4-dimethoxy-cinnamic acid ethyl ester 
• 120-14-9 3,4-dimethoxy-benzaldehyde 

Downstream Products

• 144223-81-4 5,7-dihydroxy-4-(3,4-dihydroxyphenyl)-chromen-2-one 
• 185033-52-7 7,8-dihydroxy-4-(3',4'-dimethoxyphenyl)-2H-1-chromen-2-one 
• 23982-43-6 4-(3',4'-dimethoxyphenyl)-7-hydroxycoumarin 
• 4302-52-7 4-ethynylveratrole 
• 816462-34-7 3,4-dimethoxyphenylpropioloyl chloride 
• 20583-78-2 3,4-dimethoxy-cinnamic acid ethyl ester 
• 22511-06-4 3,4-dimethoxyphenylpropiolic acid 

Relevant articles and documents

Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents

Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.

An efficient synthesis of neoflavonoid antioxidants based on Montmorillonite K-10 catalysis

A new approach to synthesis of neoflavonoids, based on a high yielding Montmorillonite K-10 catalyzed lactone ring forming cyclization process, is described. The utility of this methodology is exemplified by its employment in the preparation of the substituted 4-phenylneoflavonoids 1-8. The free radical scavenging properties of these substances were evaluated. The neoflavonoids 1 and 5, which mimic esculetin-type antioxidants, were observed to quench hydrazyl free radicals.

Enolethers and their use as a fungicide

Enolethers and thioenolethers of formula I STR1 are disclosed. The compounds are useful for combatting phytopathogenic fungi.